Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 371 results for "Victoza"

No Beneficial Outcomes With Liraglutide Tx in Advanced Heart Failure
Monthly Prescribing Reference

Diabetes Drug Victoza Might Not Help Advanced Heart Failure Pa...

By Steven Reinberg HealthDay Reporter TUESDAY, Aug. 2, 2016 (HealthDay News) -- The diabetes drug liraglutide (Victoza) doesn't appear to improve heart function in patients with advanced heart failure, a new study finds. The theory for this trial ... US News & World Report, 3 weeks ago
Liraglutide Not Beneficial in Advanced Heart Failure Physician's Briefing, 3 weeks ago
Diabetes Drug Victoza May Help the Heart: Study, 2 months ago

32 images for Victoza

FiercePharma, 1 week ago
Pharmafile, 3 weeks ago
FiercePharma, 1 month ago
diaTribe, 1 month ago
Nasdaq, 1 month ago
diaTribe, 1 month ago
AfricanSeer, 2 months ago
DataMonitor HealthCare, 2 months ago, 2 months ago
Nasdaq, 2 months ago

Novo's Victoza Diabetes Medicine Rebuffed by Express Scripts

Novo Nordisk A/S's Victoza, a diabetes treatment that dominates its class of drugs, was shunned by U.S. pharmacy benefits manager Express Scripts Holding Co. for at least the second year in a row, suggesting that the Danish company refused to ...
 Bloomberg3 weeks ago

Human medicines European public assessment report (EPAR): Victoza, liraglutide, Revision: 15, Authorised

This is a summary of the European public assessment report (EPAR) for Victoza. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ...
 European Medicines Agency1 month ago

Novo Nordisk diabetes drug Victoza fails to reduce heart failure risk

Novo Nordisk's diabetes drug Victoza (liraglutide), which was found to cut cardiovascular risks in sufferers of heart disease , has failed to deliver the same level of benefit to patients suffering from heart failure in a recent Phase II study. ...
 Pharmafile3 weeks ago Fresh off its win in CV outcomes trial, Victoza falls short in heart failure study  FiercePharma3 weeks ago Is $2.8 Billion Just The Beginning For This Novo Nordisk Diabetes Drug  Nasdaq1 month ago What Is It About Novo Nordisk's Diabetes Drug That Makes It a Top Seller?  Motley Fool2 months ago

Novo Nordisk A/S 2Q 2016 -- Forecast

=== Sales: -NovoRapid/ 2nd Quarter -Total -Victoza -Levemir NovoLog AVERAGE 28,291 5,001 4,569 5,202 Prev. Year 27,059 4,486 4,522 ...
 Morningstar.com3 weeks ago NOVO NORDISK A/S : 2Q Net Profit Surges 19%  4 Traders3 weeks ago NOVO NORDISK A/S : 2Q 2016 -- Forecast  4 Traders3 weeks ago Novo Nordisk's 2Q Net Profit Surges 19%  Investors Hub3 weeks ago

LEADER trial suggests CV benefits with Victoza

BAGSVÆRD, Denmark— Novo Nordisk recently recently announced that Victoza (liraglutide) injection 1.2 mg or 1.8 mg significantly reduced the risk of the composite primary endpoint of cardiovascular (CV) death, non-fatal myocardial infarction or ...
 Drug Discovery News2 months ago Novo Nordisk (NVO) Reports Positive Trial Results on Victoza  Nasdaq2 months ago

Physician Views Poll Results: Victoza exclusion old news but Lantus will be missed, say diabetes docs

You attempted to read Physician Views, exclusive content for FirstWord Pharma PLUS members. You currently are not registered for any FirstWord Pharma services. To gain instant access to Physician Views plus additional enhanced content and ...
 FirstWord Pharma1 week ago

Lilly's dulaglutide matches Victoza in study, but the real loser is AstraZeneca's Bydureon

Novo Nordisk's Victoza--FiercePharma file photo Eli Lilly is one step closer to launching its promising new diabetes drug dulaglutide--and one step closer to putting a crimp in Novo Nordisk's big-selling rival, Victoza. Lilly unveiled top-line ...
 FiercePharma1 month ago Will GLP market growth save Novo's Victoza from Lilly's new Trulicity?  FiercePharma1 month ago Novo Nordisk says its us vs. Eli Lilly in diabetes  BioPharma Dive2 weeks ago Novo Nordisk cuts growth forecast as profit jumps  Business Recorder3 weeks ago

Novo Nordisk (NVO) Beats Q2 Earnings, Revenues Up Y/Y

Quarterly revenues increased 3.9% year over year to $4.2 billion. The top line was driven by strong sales of Victoza, Tresiba, Saxenda and Norditropin. Sales were partly offset by the performance of modern insulin
 BioSpace2 weeks ago

Victoza Does Not Help Severe Heart Failure

Novo Nordisk's Blockbuster Diabetes Med A widely prescribed diabetes drug that has shown potential for helping weakened hearts failed to reduce deaths or rehospitalizations in a study of patients with advanced heart failure. There was a trend ...
 Pharma Live3 weeks ago Novo Nordisk A/S's Blockbuster Diabetes Med Victoza Does Not Help Severe Heart Failure  BioSpace3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Victoza
Get updated on latest news & your favorite topics right in your inbox!
More     Less